
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
A new 5-question COPD assessment tool may help identify more serious disease earlier in the primary care setting.
Obtaining a peak expiratory flow measurement and asking for a "yes" or "no" answer to 5 questions written at the 6th-grade reading level could help better identify patients with obstructive lung disease seen by primary care physicians who would most benefit from current therapies.






